Linagliptin 5 mg Tablet | PCD Pharma Manufacturer & Supplier India | Trumac Healthcare
Linagliptin 5 mg Tablet
WHO-GMP Manufacturer & PCD Pharma Franchise Supplier in India
Form: Tablet
Class: DPP-4 inhibitor (gliptin)
✓ Pan-India Monopoly PCD
✓ 1 Brand Options
Pricing, brochure & monopoly territory within 24 hrs.
Our Linagliptin 5 mg Tablet Brand Options (1 option)
Trumac Healthcare manufactures and supplies the following Linagliptin 5 mg Tablet brands for PCD pharma distribution. Click any brand to view full specifications and packaging.
Linagliptin 5 mg Tablet is manufactured under WHO-GMP-certified conditions by Trumac Healthcare and supplied for PCD/Propaganda-cum-Distribution pharma franchise on monopoly basis across India. Whether you are a PCD distributor, stockist or retail chemist, our Linagliptin 5 mg formulation comes with full quality assurance, regulatory documentation and reliable pan-India despatch.
Therapeutic Indications
- Type-2 diabetes mellitus
- Type-2 DM with chronic kidney disease (no dose adjustment needed)
- Add-on to metformin / SU / SGLT2i / insulin
- Elderly type-2 diabetics
Mechanism of Action
Linagliptin selectively inhibits DPP-4, preventing breakdown of the incretin hormones GLP-1 and GIP. Elevated incretin levels increase glucose-dependent insulin secretion and suppress glucagon — improving glycaemic control without promoting hypoglycaemia in non-eugenic states. Unlike other gliptins, linagliptin is primarily hepatically/biliary excreted, sparing the kidneys.
Dosage & Administration
- Adults: 1 tablet (5 mg) once daily, with or without food
- No dose adjustment for renal or hepatic impairment
- Use under physician supervision
Side Effects
- Nasopharyngitis
- Mild headache
- Pancreatitis (rare)
- Joint pain occasionally
- Hypoglycaemia (when combined with SU or insulin)
Contraindications
- Type-1 diabetes
- Diabetic ketoacidosis
- Hypersensitivity to linagliptin
- Pregnancy and breastfeeding
- History of severe pancreatitis
Storage
Store below 25°C.
PCD Pharma Franchise for Linagliptin 5 mg Tablet
- ✓ WHO-GMP certified manufacturing facility
- ✓ Pan-India monopoly distribution rights available
- ✓ Multiple pack sizes: 10 x 10 (Alu Alu)
- ✓ Trade-friendly PTR / PTS margins
- ✓ Free promotional material on request
- ✓ Full DCGI documentation and quality certificates supplied
Trumac Healthcare offers 1 brand option for Linagliptin 5 mg Tablet — each available in different pack sizes with trade-friendly margins. View the brand-specific pages below for detailed specifications, MRPs and packaging options.
For PCD franchise opportunities, monopoly distribution rights, or third-party contract manufacturing of Linagliptin 5 mg Tablet, contact our business development team. WhatsApp +91 9041677932 or email info@trumachealthcare.net.
Frequently Asked Questions
Who is the manufacturer of Linagliptin 5 mg Tablet?
Trumac Healthcare is a WHO-GMP certified manufacturer of Linagliptin 5 mg Tablet in India. We supply our own brand range (see brand options above) and also offer third-party contract manufacturing for PCD distributors.
Is Linagliptin 5 mg Tablet available for PCD pharma franchise on monopoly basis?
Yes. We offer Linagliptin 5 mg Tablet for PCD/Propaganda-cum-Distribution pharma franchise on monopoly basis across all districts of India. Contact our business development team for pricing and territory availability.
What pack sizes are available for Linagliptin 5 mg Tablet?
Available pack sizes include: 10 x 10 (Alu Alu).
What is the MRP / trade price for Linagliptin 5 mg Tablet?
MRPs range from ₹1550 to ₹1550 across our brand variants. Trade-friendly PTR/PTS margins available on request — WhatsApp +91 9041677932 for current rates.
How do I place an order or franchise enquiry?
WhatsApp +91 9041677932 or email info@trumachealthcare.net with your enquiry. Our team will revert within 24 hours with full pricing, brochure and franchise terms.
Ready to start your PCD franchise for Linagliptin 5 mg Tablet?